Charles Schwab Investment Management »

Cognition Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 12k 1.85
2023-09-30 $17k 12k 1.44
2023-06-30 $22k 12k 1.83

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Home Depot (HD)
Alphabet Cap Stk Cl C (GOOG)
Merck & Co (MRK)
Chevron Corporation (CVX)
Abbvie (ABBV)
Tesla Motors (TSLA)
Cisco Systems (CSCO)
Coca-Cola Company (KO)

View all positions for Charles Schwab Investment Management

Top funds holding Cognition Therapeutics

Pathstone Holdings
AIGH Capital Management
Vanguard Group
Worth Venture Partners
Kestra Advisory Services
American Financial Group
Sigma Planning
Mercer Global Advisors
Commonwealth Equity Services
Texas Capital Bank Wealth Management Services
Fca Corp
Castle Wealth Management
HighTower Advisors
Northeast Financial Consultants
Bangor Savings Bank

View all funds holding Cognition Therapeutics